我們已在上線! 進一步了解
ZVSAW圖示

ZyVersa Therapeutics, Inc. Warrants
ZVSAW

已下市

ZVSAW已於2022年12月20日下市。

 

關於: ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於ZVSAW的最新新聞文章。

價格圖表採用Lightweight Charts™實作